2017
DOI: 10.1016/j.jagp.2017.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Mobile Health Technology in Late-Life Mental Illness: A Focused Literature Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 28 publications
0
18
0
Order By: Relevance
“…We identified a large number of studies, reporting popular applications of telemental health care in various settings ( 1 - 8 , 11 - 28 ). However, we did not find a systematic review on all applications of telemental health care.…”
Section: Introductionmentioning
confidence: 99%
“…We identified a large number of studies, reporting popular applications of telemental health care in various settings ( 1 - 8 , 11 - 28 ). However, we did not find a systematic review on all applications of telemental health care.…”
Section: Introductionmentioning
confidence: 99%
“…The revolution in mobile technologies such as smart phones/ tablets, cloud-based platforms, and deep learning-driven software algorithms and miniaturized automated physiological sensors is poised to profoundly disrupt medicine [3][4][5][6][7] and, by extension, many aspects of neuropsychiatry and AD care and clinical research. [5][6][7][8] In this Perspective, we highlight four areas in which such technology could facilitate AD clinical trials: (1) Mobilizing recruitment, (2) Mobile cognitive measures, (3) Digital functional outcomes, and (4) Integrated informatics platforms.…”
Section: Introductionmentioning
confidence: 99%
“…For further information on how technology may help with care and caregiver support, readers are referred elsewhere. 4,5 MOBILIZING CLINICAL TRIAL RECRUITMENT ClinicalTrials.gov lists >450 active Alzheimer's trials needing some 70,000 volunteers-posing the challenge of how to efficiently identify, consent, and screen subjects. Prevention trials increasingly rely on expensive brain scans or spinal fluid biomarkers to identify at-risk subjects but such methods have high screen fail rates-because only about a third of asymptomatic subjects may test positive.…”
Section: Introductionmentioning
confidence: 99%
“…The review found these type of technologies to be feasible for patients and reliable for mental health domains assessment within the geriatric population. ( 24 ) Despite the fact that 76% of community-dwelling older adults rated their technology skills as poor or average in a recent survey, ( 13 ) geriatric patients in our study expressed being interested in using iPad-based symptom self-report questionnaires once they were routinely available in future clinical practice.…”
Section: Discussionmentioning
confidence: 77%